Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baihe Yuzi Prescription is a Traditional Chinese Medicine (TCM) herbal formula developed by the Hebei Hospital of Traditional Chinese Medicine. It is primarily investigated for the treatment of male infertility, specifically idiopathic oligospermia (low sperm count). The prescription is designed to improve semen parameters and modulate reproductive hormones, including testosterone, estradiol, and seminal plasma anti-mullerian hormone (AMH). In clinical trial settings, it is evaluated for its efficacy in enhancing sperm concentration and motility, potentially through the regulation of the hypothalamic-pituitary-gonadal axis or direct effects on spermatogenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Baihe Yuzi Prescription.